drugset / Trial / NCT02061384

RA-2 13-cis Retinoic Acid (Isotretinoin)

NCT02061384

Phase 2 Completed 20 enrolled University of Washington
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Men with infertility and normal hormone levels have few options for fertility treatment. Previous research work has suggested that men with infertility may have low levels of the active form of Vitamin A, called retinoic acid, in their testes. We think that giving men with low sperm counts retinoic acid may increase their sperm counts and improve their chances of fathering a pregnancy. We want to see if retinoic acid administration over twenty weeks can increase sperm production and help infertile men become fathers without the need for In vitro fertilization (IVF) and/or intracytoplasmic sperm injection (ICSI). We also want to see if adding calcitriol with retinoic acid will improve sperm motility in a sub-set of subjects.

Timeline

Start
2014-08
Primary completion
2018-12
Completion
2018-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule 0.25 ug Oral
Subject Isotretinoin Other / unclassified 20 mg